MDS Podcast

Latest Episodes:

CSF proenkephalin as a biomarker for premotor Huntington's disease Feb 09, 2026

Show notes

Dr. Mena Farag joins Dr. Eduardo de Pablo-Fernández to discuss how proenkephalin and other biomarkers can help monitor the earliest stages of Huntington's disease decades before the onset of motor symptoms. Journal CME is available until February 11, 2027
Read the article.

Collegiality and friendship - MDS 40th Anniversary Dec 08, 2025

Show notes

To celebrate the 40th Anniversay of the MDS, Dr. Michele Matarazzo sits down with two key leaders of the MDS Asian Oceanian section, Prof. Carolyn Sue and Prof. Beomseok Jeon. Together they discuss the early years of movement disorder “rock stars,” how the society has changed through their eyes, and impacts it has had on their careers.

Current genetic landscape for movement disorders • 2025 MDS Congress Oct 20, 2025

Show notes

The field of genetics often moves quickly, making it a challenge to stay informed. Dr. Gerard Saranza breaks down the current landscape, new discoveries and technologies, and what changes we can expect in the upcoming years.

Current landscape of pediatric movement disorders • 2025 MDS Congress Oct 20, 2025

Show notes

Due to genetic advancements, the pediatric movement disorder field is ever growing. Dr. Shekeeb Mohammad breaks down the current landscape of the field and how adult neurologists can advance their learning.

Combined habit reversal and acceptance and commitment therapies for tics Mar 03, 2025

Show notes

Dr. Jennifer Eisenhauer joins Dr. Sara Schaefer to discuss her recent article describing a combined therapy approach for adult patient with tics: habit reversal therapy (HRT) + acceptance and commitment therapy (ACT). They further discuss what these therapies are, their effect in tics, what is gratifying about working with patients with tics, and next steps to determine efficacy of this approach. Read the article.

CSF1R-related disorder in China May 28, 2024

Show notes

Dr. Sara Schaefer speaks with Doctors Xiaojun Huang and Jingying Wu about the phenotypic and genotypic spectrum of CSF1R-related disorder in a Chinese population, including unique clinical and radiographic characteristics.
Journal CME is available until May 21, 2025 Read the article.

Concomitant pathologies and their clinical impact in multiple system atrophy Apr 15, 2024

Show notes

Dr. Eduardo Fernandez discusses with Dr. Hiroaki Sekiya the surprising findings of his study evaluating the presence of concomitant pathologies and how they impact the disease progression in a large cohort of patients with MSA from the Mayo Clinic brain bank. Read the article

Clozapine in Parkinson's disease: Why, when and how? Feb 13, 2023

Show notes

Clozapine is a antipsychotic drug that has been marketed for decades. In this interview, Dr. Friedman shares his thoughts on its utility in Parkinson's disease along with some practical advices on how to use it in the clinic. Read the article.

COVID-19 and the Risk of Parkinsonism Oct 17, 2022

Show notes

Dr. Sara Schaefer discusses with Prof. Richard Smeyne how viruses including COVID-19 increase the susceptibility to oxidative stress-induced parkinsonism in mouse models, the historical evidence to support a virus-parkinsonism link, the biological basis for this correlation, and ways it may be prevented.
Journal CME is available until July 29, 2023 Read the article.

Cognitive and visuospatial abilities in dystonia Jun 01, 2021

Show notes

Dr. Sara Schaefer speaks with Dr. Carlos Camargo about the non-motor and prodromal features of dystonia. Read the article

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected